23andMe Holding Co. Stock News

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access,

Anne Wojcicki is the sister of former YouTube CEO Susan Wojcicki. Here's a look back at how she got her start and built a genetic-testing empire.

This healthcare company isn't without risk but is doing a good job executing on its vision.

23andMe Holding Co. (NASDAQ:ME ) Q3 2022 Earnings Conference Call February 8, 2023 4:30 PM ET Company Participants Wade Walke - VP, Investor Relations Anne Wojcicki - CEO & Co-Founder Joe Selsavage -

Shares of 23andMe Holding Co. ME, -0.40% rallied more than 12% in the extended session Wednesday after the genetics company raised guidance for 2023. 23andMe lost $92 million, or 20 cents a share, in

SOUTH SAN FRANCISCO, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access,

23andMe's stock price has been falling for several years now. But last week's drop seems to me to be driven by tax loss sellers who are indiscriminate about selling price; wanting only to harvest a ta

23andMe Holding Co. is a DNA testing company which has genetic information on over 12 million customers. The company announced a strong Q2 FY23, beating both revenue and earnings estimates for growth.

This segment originally aired on November 15, 2022. 23andMe Co-Founder and CEO Anne Wojcicki sits down with Yahoo Finance's Anjalee Khemlani at the HLTH conference to discuss the slowdown in growth, c

Biotech penny stocks with upcoming events to watch in November 2022. The post 3 Biotech Penny Stocks To Watch After MACK Stock Jumps 240% appeared first on Penny Stocks to Buy, Picks, News and Informa

23andMe Holding Co. (NASDAQ:ME ) Q2 2023 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Wade Walke - Vice President-Investor Relations Anne Wojcicki - Chief Executive Office

These companies haven't performed as well as I thought they would, but I don't plan to sell.

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company with a mission to help people ac

They're both using unique and highly efficient approaches to developing and deploying their medicines.

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company with a mission to help people ac